UT Health Science Center San Antonio seeks volunteers to join VIVA-MIND study of an oral drug for Alzheimer’s

Volunteers 50 to 89 with a diagnosis of mild cognitive impairment or probable mild AD may ask about eligibility to participate in VIVA-MIND, a study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems.